SCHEDULE 1

PROHIBITED SUBSTANCES

PART I

(a) Anabolic Agents

(I) Androgenic Anabolic Steroids e.g.

androstenedione

bolasterone

methyltestosterone

boldenone

nandrolone

chlordehydromethyltestosterone

norethandrolone

clostebol

oxandrolone

dehydroepiandrosterone

oxymesterone

dihydrotestosterone*

oxymetholone

fluoxymesterone

stanozolol

gestrinone

testosterone**

mesterolone

methandienone

methenolone

and chemically or pharmacologically related compounds

* Dihydrotestosterone: a sample will be deemed to be positive for dihydrotestosterone where the

concentrations of dihydrotestosterone and its metabolites and/or their ratios to non-5alpha-steroids

in urine so exceed the range of values normally found in humans as not to be

consistent with normal endogenous production.

** Testosterone: a sample will be deemed to be positive for testosterone where either the ratio in

urine of testosterone to epitestosterone, or the concentration of testosterone in urine, so

exceeds the range of values normally found in humans as not to be consistent with normal

endogenous production.

A sample will not be regarded as positive for dihydrotestosterone or testosterone where an

athlete proves by clear and convincing evidence that the abnormal ratio or concentration is

attributable to a pathological or physiological condition.

(II) Other Anabolic Agents e.g.

beta-2-agonists #

(e.g. bambuterol, clenbuterol, formoterol, reproterol)

# Exceptionally, the administration of the beta-2-agonists salbutamol, salmeterol or

terbutaline are permitted by inhalation where prescribed for

therapeutic purposes by properly qualified medical personnel and

where prior clearance has been given by the relevant National

Federation or the IAAF. (For IAAF procedure, see Chapter 5).

(b) Amphetamines: e.g.

amineptine mesocarb

amphetamine methoxyphenamine

amphetaminil methylamphetamine

benzphetamine methylphenidate

bromantan morazone

carphedon pemoline

mesocarb

methoxyphenamine

methylamphetamine

methylphenidate

morazone

pemoline

dimethylamphetamine

phendimetrazine

ethylamphetamine

phenmetrazine

fenethylline

pipradrol

fenproporex

pyrovalerone

furfenorex

selegiline

mefenorex

and chemically or pharmacologically related compounds.

(c) Peptide, Glycoprotein and Glucocorticoid Hormones and Analogues, e.g.

Corticosteroids by oral, intramuscular or intravenous application.

Chorionic Gonadotrophin (HCG - human chorionic gonadotrophin): it is well known that the

administration to males of human chorionic gonadotrophin and other compounds with related activity

leads to an increased rate of production of endogenous androgenic steroids and is considered

equivalent to the exogenous administration of testosterone.

A sample will be deemed to be positive for HCG where the concentration of HCG in urine so exceeds

the range of values normally found in humans as not to be consistent with normal endogenous

production.

A sample will not be regarded as positive for HCG where an athlete proves by clear and convincing

evidence that the abnormal concentration is attributable to a pathological or physiological condition.

Corticotrophin (ACTH): corticotrophin has been misused to increase the blood levels of endogenous

corticosteroids notably to obtain the euphoric effect of corticosteroids. The application of

corticotrophin is considered to be equivalent to the oral, intra-muscular or intravenous application of

corticosteroids.

Growth Hormone (HGH, somatotrophin): the misuse of growth hormone in sport is deemed to be

unethical and dangerous because of various adverse effects, for example, allergic reactions,

diabetogenic effects, and acromegaly when applied in high doses.

Erythropoietin (EPO) is a glycoprotein produced principally in the kidneys which stimulates the

production of red blood corpuscles.

All the respective releasing factors (and their analogues) of the above-mentioned substances are also

banned.

(d) Cocaine

(e) Prohibited Techniques:

(see SCHEDULE 2)

PART II

(a) Stimulants: e.g.

PART II

(a) Stimulants: e.g.

amiphenazole

ethamivan

caffeine*

fencamfamin

cathine

methylephedrine

chlorphentermine

nikethamide

clobenzorex

pentetrazol

clorprenaline

phentermine

cropropamide

phenylpropanolamine

crotethamide

prolintane

ephedrine

propylhexedrine

etafedrine

strychnine

and chemically or pharmacologically related compounds

* For caffeine the definition of a positive finding is one in which the concentration in

urine exceeds 12 micrograms/millilitre.

A sample may not be regarded as positive for caffeine where an athlete

proves by clear and convincing evidence that the abnormal concentration is attributable

to a physiological condition.

(b) Narcotic Analgesics: e.g.

alphaprodine

methadone

anileridine

morphine*

buprenorphine

nalbuphine

dextromoramide

pentazocine

diamorphine

pentazocine

dipipanone

pethidine

ethoheptazine

phenazocine

levorphanol

trimeperidine

and chemically or pharmacologically related compounds

Note - codeine, dextromethorphan, dextropropoxyphene

dihydrocodeine, diphenoxylate, ethylmorphine and pholcodine are

permitted.

* For morphine the definition of a positive finding is one in which the

concentration in the urine exceeds

1 microgram/millilitre of free and conjugated morphine.

PART III

Substances and prohibited techniques to be detected during

Out-Of-Competition Testing.

(a) Anabolic Agents

(see PART I (a) )

(b) Peptide, Glycoprotein and Glucocorticoid Hormones and Analogues

(see PART I (c) )

(c) Prohibited Techniques

(see SCHEDULE 2)



SCHEDULE 2

PROHIBITED TECHNIQUES

The expression "prohibited techniques" shall include:

i) Blood doping including the use of erythropoietin (EPO).

See SCHEDULE 1

PART 1(c)

ii) Use or attempted use of substances and of methods e.g. diuretics, which alter the integrity and

validity of urine samples used in doping controls. Examples of prohibited techniques are

catheterisation, urine substitution and/or tampering, inhibition of renal excretion, e.g. by

probenecid, bromantan and related compounds.

iii) Epitestosterone: a sample will be deemed to be positive for epitestosterone where either the

concentration of epitestosterone in urine, or the ratio of epitestosterone to other endogenous

steroids in urine, so exceeds the range of values normally found in humans as not to be

consistent with normal endogenous production.